Bio & Heath Committee

The Bio & Health Committee of KUICA provides a collaborative platform to advance bilateral cooperation in life sciences, pharmaceuticals, and healthcare technologies. As both nations invest heavily in biotechnology, personalized medicine, and digital health, the committee enables stakeholders to share expertise, align regulatory frameworks, and pursue joint initiatives.

The committee encourages collaboration in drug development, vaccine research, medical devices, bioinformatics, and healthcare AI, while also addressing challenges such as regulatory harmonization, clinical trials, and ethical practices. Through active partnerships, it supports stronger health ecosystems and enhances resilience against future health crises.

Key Functions

• Policy Alignment: Facilitate dialogue on regulatory frameworks for biotechnology, healthcare, and pharmaceuticals.

  
  

• Joint R&D Promotion: Encourage collaborative research in vaccines, precision medicine, and advanced therapeutics.

  
  

• Healthcare Innovation: Support projects in digital health, telemedicine, and AI-driven medical applications.

  
  

• Networking Opportunities: Connect Korean and U.S. biotech firms, startups, and investors.

  
  

• Knowledge Sharing: Highlight successful collaborations and global best practices in bio and health sectors.

  
  

• Public Health Impact: Contribute to stronger healthcare resilience and global health improvements.